NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/21/2021
Back to search
Official data from USPTO
CCPLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
01/21/2021
Trademark type
Word
Nice classes
5, 10
Filing date
06/19/2007
Registration date
01/18/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/21/2021
Last transaction
01/21/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
24
Owner location
MALMO, SE
Examiner
FALK, ERIN
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
SVAR LIFE SCIENCE AB
Euro-Diagnostica AB
Representatives
Kevin A. Thompson LADAS & PARRY LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic reagents; diagnostic agentspreparations and substances for medical purposes; kits comprised principally of medical diagnostic assays for testing of bodily fluids; testing kits containing peptide substrates used in analyzing and detecting certain proteins indicating onset of human joint inflammatory diseasefor clinical or laboratory use; in vitro diagnostic test kits for detection of rheumatoid arthritis comprised primarily of reagents for medical diagnostic use; biomedical compoundspeptide substrates used in analyzing and detecting certain antibodies to cyclic citrullinated peptides for clinical or medical laboratory use; testing kits containing peptide substrates used in analyzing and detecting certain antibodies to cyclic citrullinated peptides for clinical or medical laboratory use; medical diagnostic test kits for the detection of rheumatoid arthritisprincipally comprised of microtitre peptide substrates and reagents; medical diagnostic test kitsfeaturing reagents and peptide coated receptacle substratesfor the detection of auto-immune joint disease; medical diagnostic enzyme linked immunoassay (ELISA) testscomprised primarily of medical diagnostic preparations in the nature of bodily serum(a) holders such as microtitre plates with wells having areas coated with antigenic preparations(s) for detection of antibodies to cyclic citrullinated peptides (CCP)for clinical or laboratory use
Class 10
Apparatus for clinical diagnosis; apparatus for blood analysis; blood testing apparatus
Publications
History of USPTO decisions and trademark events.
58 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/21/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/21/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
01/19/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/26/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/18/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/06/2017
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/06/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/06/2017
E815
TEAS SECTION 8 & 15 RECEIVED
01/03/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2010
PUBO
PUBLISHED FOR OPPOSITION
11/02/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/27/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2010
DMCC
DATA MODIFICATION COMPLETED
09/23/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2010
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/06/2010
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/06/2010
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/06/2010
CNSI
SUSPENSION INQUIRY WRITTEN
08/06/2010
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/09/2010
ALIE
ASSIGNED TO LIE
07/09/2010
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/05/2010
GNSL
LETTER OF SUSPENSION E-MAILED
01/05/2010
CNSL
SUSPENSION LETTER WRITTEN
01/05/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/07/2009
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/16/2009
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/16/2009
CNSI
SUSPENSION INQUIRY WRITTEN
06/16/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/26/2009
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/26/2008
GNSL
LETTER OF SUSPENSION E-MAILED
11/26/2008
CNSL
SUSPENSION LETTER WRITTEN
11/26/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/15/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/10/2008
GNRT
NON-FINAL ACTION E-MAILED
09/10/2008
CNRT
NON-FINAL ACTION WRITTEN
09/10/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2008
ALIE
ASSIGNED TO LIE
08/02/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/31/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2008
GNRT
NON-FINAL ACTION E-MAILED
02/06/2008
CNRT
NON-FINAL ACTION WRITTEN
02/06/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/27/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/27/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2007
GNRT
NON-FINAL ACTION E-MAILED
10/10/2007
CNRT
NON-FINAL ACTION WRITTEN
10/10/2007
DOCK
ASSIGNED TO EXAMINER
09/21/2007
NWAP
NEW APPLICATION ENTERED
06/22/2007
Continuous trademark protection
Get notified about every new filing that threatens CCPLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.